Boehringer Ingelheim Enterprise Account Executive Salaries in New York
The average Boehringer Ingelheim Enterprise Account Executive in New York earns an estimated $131,926 annually, which includes an estimated base salary of $93,113 with a $38,813 bonus. Boehringer Ingelheim's Enterprise Account Executive compensation is $18,452 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Boehringer Ingelheim in New York can range from $86,317 - $185,000.
In New York, The Business Development Department at Boehringer Ingelheim earns $129 more on average than the Engineering Department.
Last updated 5 months ago.
- $93,113
- avg. base
- $38,813
- avg. bonus
Enterprise Account Executive Salaries at Boehringer Ingelheim
In New York, Enterprise Account Executives earn $5,471 more than Account Managers, and $625 less than Account Executives.
Compensation at Boehringer Ingelheim by Department
In New York, The Business Development Department averages $129 more than the Engineering Department, and $13,518 less than the Product Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Boehringer Ingelheim reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Boehringer Ingelheim reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Boehringer Ingelheim Rate Their Compensation
The majority of Enterprise Account Executives at Boehringer Ingelheim believe they're compensated fairly. The vast majority (72%) of Enterprise Account Executives at Boehringer Ingelheim are satisfied with their benefits. See more compensation ratings at Boehringer Ingelheim
